Replies to post #100052 on Biotech Values

[DewDiligence]

Brilinta’s European brand name is Brilique (which sounds like something to clean a barbeque grill):

http://www.astrazeneca.com/Media/Press-releases/Article/European-Commission-Approves-Brilique

The drug received rubber-stamp approval from the EU Commission today for prevention of thrombosis in patients with ACS; it had been endorsed by the CHMP on 9/24/10.

In the US, the PDUFA date for Brilinta is 12/16/10; an FDA advisory panel backed approval by a 7-1 vote on 7/28/10 (#msg-52749102).